ADC Therapeutics SA Number Of Share Options Granted In Share-based Payment Arrangement
ADC Therapeutics SA (ADCT) reported Number Of Share Options Granted In Share-based Payment Arrangement of 3.44 million shares for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2023-11-07
- ADC Therapeutics SA number of share options granted in share-based payment arrangement for the quarter ending 2023-09-30 was 295.50K shares, a 57.38% decline year-over-year.
- ADC Therapeutics SA number of share options granted in share-based payment arrangement for the quarter ending 2023-06-30 was 309.90K shares, a 73.77% decline year-over-year.
- ADC Therapeutics SA number of share options granted in share-based payment arrangement for the quarter ending 2023-03-31 was 2.83M shares, a 37.28% increase year-over-year.
- ADC Therapeutics SA number of share options granted in share-based payment arrangement for the quarter ending 2022-12-31 was 1.82M shares, a 448.52% increase year-over-year.
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 3 month | Number Of Share Options Granted In Share-based Payment Arrangement 6 month | Number Of Share Options Granted In Share-based Payment Arrangement 9 month | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2023-09-30 | 295.50K shares derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 605.40K shares derived: sum of 2 quarters · filed 2023-11-07 | 3.44M shares 6-K · filed 2023-11-07 | 5.25M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 309.90K shares derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | 3.14M shares 6-K · filed 2023-08-08 | 4.96M shares derived: sum of 3 quarters · filed 2023-08-08 | 5.65M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 2.83M shares 6-K · filed 2023-05-09 | 4.65M shares derived: sum of 2 quarters · filed 2023-05-09 | 5.34M shares derived: sum of 3 quarters · filed 2023-05-09 | 6.52M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 1.82M shares derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | 2.51M shares derived: sum of 2 quarters · filed 2023-03-15 | 3.69M shares derived: sum of 3 quarters · filed 2023-03-15 | 5.75M shares 20-F · filed 2023-03-15 |
| 2022-09-30 | 693.34K shares derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | 1.87M shares derived: sum of 2 quarters · filed 2022-11-08 | 3.94M shares 6-K · filed 2022-11-08 | 4.27M shares derived: sum of 4 quarters · filed 2023-03-15 |
| 2022-06-30 | 1.18M shares derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | 3.24M shares 6-K · filed 2022-08-09 | 3.58M shares derived: sum of 3 quarters · filed 2023-03-15 | 3.74M shares derived: sum of 4 quarters · filed 2023-03-15 |
| 2022-03-31 | 2.06M shares 6-K · filed 2022-05-09 | 2.39M shares derived: sum of 2 quarters · filed 2023-03-15 | 2.56M shares derived: sum of 3 quarters · filed 2023-03-15 | 2.68M shares derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-12-31 | 331.39K shares derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | 494.62K shares derived: sum of 2 quarters · filed 2023-03-15 | 613.76K shares derived: sum of 3 quarters · filed 2023-03-15 | 2.57M shares 20-F · filed 2023-03-15 |
| 2021-09-30 | 163.23K shares derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | 282.37K shares derived: sum of 2 quarters · filed 2021-11-02 | 2.24M shares 6-K · filed 2021-11-02 | |
| 2021-06-30 | 119.14K shares derived: 6-K 6 month − 6-K 3 month · filed 2021-08-03 | 2.08M shares 6-K · filed 2021-08-03 | ||
| 2021-03-31 | 1.96M shares 6-K · filed 2021-05-06 | |||
| 2020-12-31 | 3.35M shares 20-F · filed 2023-03-15 | |||
| 2019-12-31 | 1.02M shares 20-F · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |